RNA疫苗:酵母作为一种新型抗原载体
Anna Jéssica Duarte Silva1, Mylenna Máyra Gois de Sousa1, Larissa Silva de Macêdo1
1Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil.
Vaccines
|August 26, 2023
概括
基于酵母的输送系统对RNA疫苗具有前景,利用它们的天然辅助性质和携带核酸的能力来有效地进行免疫反应. 需要进一步的研究,以充分确定它们的潜力与蛋白质抗原输送相比.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 在RNA操纵方面的技术进步扩大了其在疫苗开发中的应用.
- RNA疫苗利用合成mRNA来直接转化抗原并引起免疫反应.
- 有效的输送工具对于RNA疫苗的成功至关重要.
研究的目的:
- 提供酵母及其衍生品作为RNA基疫苗的输送系统的概述.
- 讨论基于酵母的RNA疫苗的当前挑战和未来前景.
主要方法:
- 关于酵母作为抗原的传递系统的现有文献的审查.
- 对酵母细胞壁成分 (β-葡萄糖,曼) 进行辅助性特性分析.
- 对酵母微/纳米颗粒核酸承载能力和免疫细胞向的评估.
主要成果:
- 由于β-葡萄糖和曼南,酵母具有固有的辅助性质.
- 酵母微/纳米颗粒可以封装核酸,促进口服免疫,并向抗原呈现细胞 (APC).
- 酵母适合提供RNA干扰 (RNAi) 疗法.
结论:
- 酵母为基于RNA的疫苗输送提供了一个有前途的战略,在免疫调节和核酸运输方面提供了优势.
- 酵母用于RNA疫苗的应用不如蛋白质抗原那么成熟,大多数研究都在临床前阶段.
- 需要进一步的研究来克服挑战,并充分发挥酵母基RNA疫苗的潜力.
相关概念视频
Yeast Signaling
14.7K
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
14.7K
Viruses with RNA Genomes
55
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
55
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
Types of RNA
63.9K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.9K


